Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00909935 · ClinicalTrials.gov registry record
The Pharmacokinetics of Dexmedetomidine in Children
A clinical trial, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- 40
- Enrollment target
NCT00909935 is a clinical trial that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 40 participants.
The verdict
NCT00909935 was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study is designed to identify the plasma concentrations which are required to achieve adequate sedation, using a Ramsay Sedation Scale. As an alpha 2 agonist, dexmedetomidine can elicit hemodynamic changes, fluctuations in blood pressure and heart rate. This study will attempt to determine whether these changes can be predicted by plasma concentrations.
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00909935
The ClinicalTrials.gov registry entry for NCT00909935 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT00909935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00909935 about?
NCT00909935 is a clinical study titled "The Pharmacokinetics of Dexmedetomidine in Children". This study is designed to identify the plasma concentrations which are required to achieve adequate sedation, using a Ramsay Sedation Scale. As an alpha 2 agonist, dexmedetomidine can elicit hemodynamic changes, fluctuations in blood pressure and heart rate. This study will attempt to determine whet...
What is the current status of trial NCT00909935?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2011-04. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00909935?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00909935?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.